Opdualag - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of targeted protein degradation research as SK Life Science Labs presents new preclinical p300 and PRMT5 cancer data at AACR 2026.

Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight

Why Cerebras’ IPO filing looks less like a chip listing and more like an AI infrastructure wager

What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence

Lycra launches VintageFX fibre at Kingpins Amsterdam as denim makers chase vintage looks without fit failure

Lycra has spotted denim’s next problem, and VintageFX is its answer

Read More

Pharma Industry News

Bristol Myers Squibb’s Opdualag fails to meet primary endpoint in Phase 3 trial

Bristol Myers Squibb has announced that its Phase 3 RELATIVITY-098 clinical trial, designed to evaluate Opdualag (nivolumab and…

byPallavi Madhiraju

February 14, 2025

web analytics